Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lymphoma, B-Cell × Immunotherapy, Adoptive × Clear all

Phase

Status

Recruiting 9 Unknown 4 Active not recruiting 3 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Burkitt Lymphoma 2 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Carcinoma, Pancreatic Ductal 1

Interventions

obinutuzumab 3 fludarabine 3 Rituximab 3 Cyclophosphamide 3 tafasitamab 2 relmacabtagene autoleucel 2 zanubrutinib 1 venetoclax 1 tisagenlecleucel 1 resiniferatoxin 1 pomalidomide 1 polatuzumab vedotin 1 pirtobrutinib 1 glofitamab 1 Tretinoin 1 Specimen Handling 1 Radiotherapy 1 Interleukin-2 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07032324 2025-06-23

CT1190B

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Not yet recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡